Location [1]
Protein [2]
Vascular endothelial growth factor A
Synonyms [1]

Vascular endothelial growth factor A (VEGFA) is a gene that encodes a member of the PDGF/VEGF growth factor family. The protein functions as a glycosylated mitogen and acts on endothelial cells to increase vascular permeability, angiogenesis, vasculogenesis, endothelial cell growth, and cell migration. The protein also inhibits apoptosis. Missense mutations, nonsense mutations, silent mutations, and frameshift insertions are observed in cancers such as endometrial cancer, intestinal cancer, and skin cancer.

VEGFA is altered in 0.53% of all cancers with lung adenocarcinoma, osteosarcoma, breast invasive ductal carcinoma, colon adenocarcinoma, and adenocarcinoma of the gastroesophageal junction having the greatest prevalence of alterations [3].

VEGFA GENIE Cases - Top Diseases

The most common alterations in VEGFA are VEGFA Amplification (0.42%) and VEGFA Loss (0.01%) [3].

VEGFA GENIE Cases - Top Alterations

Significance of VEGFA in Diseases

Non-Small Cell Lung Carcinoma +

Esophageal Carcinoma +

Gastric Carcinoma +

Urothelial Carcinoma +

Hepatobiliary Neoplasm +

Malignant Hepatobiliary Neoplasm +

Malignant Solid Tumor +

Breast Carcinoma +

Pancreatic Carcinoma +

Adenocarcinoma Of The Gastroesophageal Junction +

Gastrointestinal Stromal Tumor +

Lip And Oral Cavity Carcinoma +

Malignant Laryngeal Neoplasm +

Malignant Salivary Gland Neoplasm +

Nasal Cavity And Paranasal Sinus Carcinoma +

Nasopharyngeal Carcinoma +

Oropharyngeal Carcinoma +

Small Cell Lung Carcinoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.